AIDS Cases Diagnosed in 1997 and 1998
By Sex, Race/Ethnicity, Age at Diagnosis, and Risk Exposure
Table 2: 1998
HIV/AIDS Surveillance Supplemental Report Vol. 5/No. 3
From U.S. Centers for Disease Control and Prevention
January 5, 2000
| Estimated Male Adult/Adolescent AIDS Cases Diagnosed in 1998 Adjusted for Reporting Delays and Risk Redistribution |
| |
Age at Diagnosis |
13-24 |
25-39 |
40-64 |
65+ |
| Exposure Category |
No. |
(%) |
No. |
(%) |
No. |
(%) |
No. |
(%) |
| White, Not Hispanic |
Men who have sex with men (MSM) |
130 |
66.0 |
4,752 |
73.4 |
3,662 |
70.9 |
133 |
71.5 |
| Injection drug use (IDU) |
17 |
8.6 |
797 |
12.3 |
806 |
15.6 |
19 |
10.2 |
| MSM and IDU |
27 |
13.7 |
536 |
8.3 |
325 |
6.3 |
6 |
3.2 |
| Hemophilia/coagulation disorder |
9 |
4.6 |
55 |
0.8 |
22 |
0.4 |
1 |
0.5 |
| Blood transfusion/components |
4 |
2.0 |
30 |
0.5 |
46 |
0.9 |
5 |
2.7 |
| Heterosexual contact |
9 |
4.6 |
294 |
4.5 |
291 |
5.6 |
21 |
11.3 |
| Other |
1 |
0.5 |
11 |
0.2 |
14 |
0.3 |
1 |
0.5 |
| Total |
197 |
|
6,475 |
|
5,166 |
|
186 |
|
| Black, Not Hispanic |
Men who have sex with men (MSM) |
267 |
61.0 |
3,486 |
50.1 |
2,109 |
31.2 |
96 |
32.5 |
| Injection drug use (IDU) |
64 |
14.6 |
1,826 |
26.2 |
3,029 |
44.8 |
77 |
26.1 |
| MSM and IDU |
16 |
3.7 |
438 |
6.3 |
446 |
6.6 |
9 |
3.1 |
| Hemophilia/coagulation disorder |
5 |
1.1 |
16 |
0.2 |
22 |
0.3 |
4 |
1.4 |
| Blood transfusion/components |
5 |
1.1 |
33 |
0.5 |
40 |
0.6 |
6 |
2.0 |
| Heterosexual contact |
73 |
16.7 |
1,145 |
16.4 |
1,100 |
16.3 |
102 |
34.6 |
| Other |
8 |
1.8 |
17 |
0.2 |
16 |
0.2 |
1 |
0.3 |
| Total |
438 |
|
6,961 |
|
6,762 |
|
295 |
|
| Hispanic |
Men who have sex with men (MSM) |
148 |
58.0 |
1,952 |
50.5 |
1,083 |
40.7 |
42 |
37.5 |
| Injection drug use (IDU) |
52 |
20.4 |
1,179 |
30.5 |
1,042 |
39.2 |
27 |
24.1 |
| MSM and IDU |
8 |
3.1 |
235 |
6.1 |
108 |
4.1 |
2 |
1.8 |
| Hemophilia/coagulation disorder |
6 |
2.4 |
8 |
0.2 |
5 |
0.2 |
2 |
1.8 |
| Blood transfusion/components |
1 |
0.4 |
18 |
0.5 |
17 |
0.6 |
1 |
0.9 |
| Heterosexual contact |
39 |
15.3 |
456 |
11.8 |
398 |
15.0 |
38 |
33.9 |
| Other |
1 |
0.4 |
15 |
0.4 |
7 |
0.3 |
0 |
· |
| Total |
255 |
|
3,863 |
|
2,660 |
|
112 |
|
| Asian/Pacific Islander |
Men who have sex with men (MSM) |
9 |
90.0 |
104 |
64.2 |
77 |
67.0 |
1 |
100 |
| Injection drug use (IDU) |
0 |
· |
19 |
11.7 |
20 |
17.4 |
0 |
· |
| MSM and IDU |
0 |
· |
9 |
5.6 |
5 |
4.3 |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
2 |
1.2 |
1 |
0.9 |
0 |
· |
| Blood transfusion/components |
1 |
10.0 |
4 |
2.5 |
0 |
· |
0 |
· |
| Heterosexual contact |
0 |
· |
23 |
14.2 |
11 |
9.6 |
0 |
· |
| Other |
0 |
· |
1 |
0.6 |
1 |
0.9 |
0 |
· |
| Total |
10 |
|
162 |
|
115 |
|
1 |
|
| American Indian/Alaska Native |
Men who have sex with men (MSM) |
3 |
60.0 |
36 |
54.5 |
13 |
40.6 |
2 |
100 |
| Injection drug use (IDU) |
0 |
· |
16 |
24.2 |
11 |
34.4 |
0 |
· |
| MSM and IDU |
2 |
40.0 |
10 |
15.2 |
6 |
18.8 |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
1 |
1.5 |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Heterosexual contact |
0 |
· |
3 |
4.5 |
2 |
6.3 |
0 |
· |
| Other |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Total |
5 |
|
66 |
|
32 |
|
2 |
|
| Male Subtotal* |
|
910 |
|
17,569 |
|
14,776 |
|
596 |
|
| *Totals include cases with unknown or missing race/ethnicity data. |
| Estimated Female Adult/Adolescent AIDS Cases Diagnosed in 1998 Adjusted for Reporting Delays and Risk Redistribution |
| |
Age at Diagnosis |
13-24 |
25-39 |
40-64 |
65+ |
| Exposure Category |
No. |
(%) |
No. |
(%) |
No. |
(%) |
No. |
(%) |
| White, Not Hispanic |
Injection drug use (IDU) |
33 |
26.8 |
413 |
41.5 |
278 |
42.1 |
4 |
12.1 |
| Hemophilia/coagulation disorder |
1 |
0.8 |
2 |
0.2 |
1 |
0.2 |
0 |
· |
| Blood transfusion/components |
2 |
1.6 |
20 |
2.0 |
23 |
3.5 |
7 |
21.2 |
| Heterosexual contact |
85 |
69.1 |
552 |
55.5 |
353 |
53.4 |
22 |
66.7 |
| Other |
2 |
1.6 |
7 |
0.7 |
6 |
0.9 |
0 |
· |
| Total |
123 |
|
994 |
|
661 |
|
33 |
|
| Black, Not Hispanic |
Injection drug use (IDU) |
81 |
18.1 |
1,222 |
33.8 |
1,043 |
42.3 |
21 |
25.6 |
| Hemophilia/coagulation disorder |
1 |
0.2 |
17 |
0.5 |
14 |
0.6 |
0 |
· |
| Blood transfusion/components |
5 |
1.1 |
62 |
1.7 |
50 |
2.0 |
3 |
3.7 |
| Heterosexual contact |
351 |
78.5 |
2,295 |
63.5 |
1,349 |
54.7 |
57 |
69.5 |
| Other |
9 |
2.0 |
17 |
0.5 |
8 |
0.3 |
1 |
1.2 |
| Total |
447 |
|
3,613 |
|
2,464 |
|
82 |
|
| Hispanic |
Injection drug use (IDU) |
24 |
21.8 |
367 |
36.3 |
253 |
33.2 |
6 |
15.8 |
| Hemophilia/coagulation disorder |
1 |
0.9 |
3 |
0.3 |
5 |
0.7 |
2 |
5.3 |
| Blood transfusion/components |
3 |
2.7 |
17 |
1.7 |
15 |
2.0 |
1 |
2.6 |
| Heterosexual contact |
79 |
71.8 |
621 |
61.4 |
487 |
63.8 |
29 |
76.3 |
| Other |
3 |
2.7 |
4 |
0.4 |
3 |
0.4 |
0 |
· |
| Total |
110 |
|
1,012 |
|
763 |
|
38 |
|
| Asian/Pacific Islander |
Injection drug use (IDU) |
0 |
· |
5 |
23.8 |
6 |
26.1 |
1 |
100 |
| Hemophilia/coagulation disorder |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
1 |
4.8 |
0 |
· |
0 |
· |
| Heterosexual contact |
5 |
100 |
15 |
71.4 |
17 |
73.9 |
0 |
· |
| Other |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Total |
5 |
|
21 |
|
23 |
|
1 |
|
| American Indian/Alaska Native |
Injection drug use (IDU) |
1 |
33.3 |
9 |
60.0 |
7 |
43.8 |
0 |
· |
| Hemophilia/coagulation disorder |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Blood transfusion/components |
0 |
· |
0 |
· |
1 |
6.3 |
0 |
· |
| Heterosexual contact |
2 |
66.7 |
6 |
40.0 |
8 |
50.0 |
1 |
100 |
| Other |
0 |
· |
0 |
· |
0 |
· |
0 |
· |
| Total |
3 |
|
15 |
|
16 |
|
1 |
|
| Female Subtotal* |
|
688 |
|
5,666 |
|
3,936 |
|
155 |
|
| 1998 Total* |
|
1,598 |
|
23,235 |
|
18,712 |
|
751 |
|
| *Totals include cases with unknown or missing race/ethnicity data. |
|
|
Advertisement
|
Email
Print-Friendly
Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. 
